📰 Human Use News
Page 43 - Human Use News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Human Use. Real-time updates on events, politics, business and more.
October 5, 2023
L’Agence Nationale de Sécurité du Médicament et des produits de santé , the national authority for authorizing medicinal products in France, has granted “accès compassionnel” to AMX0035 ...
October 2, 2023
During Salvador Allende’s brief term in power, a revolutionary project sought to use technology, specifically information from factories for real-time planning and interventions in the economy. What does this tell us about knowledge and the struggle over the infrastructure that produces it?
September 29, 2023
(Reuters) - Drugmaker PTC Therapeutics said on Thursday it plans to cut workforce, which would impact about 25% of the organization, as it aims to red...
September 29, 2023
Geron Corporation , a late-stage clinical biopharmaceutical company, today announced that the European Medicines Agency has validated the Marketing Authorization Application for imetelstat, a...
September 29, 2023
PRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL INFORMATION FOR THE FIRST HALF OF 2023 AND THE KEY EVENTS OF THE PERIOD Clinical development strategy based on two platforms: the...
September 29, 2023
NEW YORK, Sept. 29, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. . Such investors are advised to contact Robert S. Willoughby at...
September 29, 2023
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. ("PTC" or the "Company") (NASDAQ: PTCT). Such investors...
September 28, 2023
BAD VILBEL, Germany and STOCKHOLM, Sept. 28, 2023 /PRNewswire/ -- Partners STADA and Calliditas Therapeutics...
September 28, 2023
Drugmaker PTC Therapeutics said on Thursday it plans to cut workforce, which would impact about 25% of the organization, as it aims to reduce its yearly operating expenses. The workforce...
September 27, 2023
On September 19, 2023, the U.S. Food and Drug Administration ("FDA" or "the Agency") published a draft guidance, Regulatory Considerations for Prescription Drug Use-Related Software (the "Guidance")...